CLUSTER filed Aug 27, 2026 at 16:30 ET
Two Corcept Therapeutics insiders sold a total of ~$788K in shares over a week, with the bulk ($740K) from Sean Maduck (See Remarks) on August 25 following a derivative exercise. Director David Mahoney sold a small $48K lot on August 18. The total value is just 0.006% of Corcept's $12.6B market cap, a trivial amount that does not indicate a bearish signal. The cluster is a sell, but the dollar amount is immaterial relative to company size, and the Maduck sale appears to be a routine cash-out following option exercise, not an informed bearish bet. The cross-filing actuarial verdicts show multiple AMPLIFIER combos, but none apply here because the cluster value is below the materiality threshold. The 30-day prior insider activity shows $17.3M in sells, consistent with ongoing routine diversification. No material bearish read-through.